Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
CN Bio opened new contract research facilities at Cambridge Science Park. The Company’s laboratory space has been doubled in response to the increasing market demand for OOC services as the technology gains traction within drug discovery and ...
read more
The Canadain Government has signed a new contract with GlaxoSmithKline to support sustained influenza pandemic readiness.
read more
Celegence, a global provider of regulatory affairs services and solutions for the life sciences industry, has announced the acquisition of Qdossier, a supplier of end-to-end services to support document and dossier lifecycle management for ...
read more
Samsung Biologics signed an agreement with the Incheon Free Economic Zone (IFEZ) on July 18th to build out its second Bio Campus.
read more
Discovery Life Sciences™ has acquired AllCells®, a provider of clinical-grade (GMP-compliant) and Research Use Only (RUO) primary cell products. With more than 30 years of collective cell and gene therapy (CGT) experience, AllCells and Discovery will...
read more
Societal CDMO, Inc. has signed an amendment to its license and supply agreement with Lannett Company for the marketing of Verapamil PM and Verelan SR. Under terms of the amendment, Societal will now receive improved overall economics, including a 10%...
read more
Piramal Pharma Limited’s Pharma Solutions business, held a Grand Opening to celebrate the official inauguration of a new active pharmaceutical ingredient (API) plant at the company’s site in Aurora, Ontario.
read more
Transpire Bio, a development-stage pharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, has announced a definitive agreement with Recipharm to develop TRB-1 and TRB-2, inhaled medicines for the ...
read more
Vaccizone has selected Exothera S.A. to fast-track process development of its SARS-CoV-2 vaccine for European clinical trials.
read more
Pelican Products Inc. has appointed Mike Davis as group CEO of its Peli BioThermal Division, the life science industry's partner from discovery to distribution.
read more
Solvias has acquired Utrecht, Netherlands-based Cergentis. The acquisition bolsters Solvias' platform of biologics and cell and gene therapy (CGT) testing solutions.
read more
QHP Capital, the management company for NovaQuest Private Equity, announced its acquisition of Lexitas Pharma Services, a full-service ophthalmology contract research organization (“CRO”) supporting biopharmaceutical and medical device clinical ...
read more
Piramal Pharma Ltd (PPL) announced the addition of three members to its board of directors. The company has added Mr. Peter Stevenson, Ms. Nathalie Leitch and Mr. Sridhar Gorthi to the board.
read more
WuXi STA, a subsidiary of WuXi AppTec, announced the opening of a new large-scale oligonucleotide and peptide manufacturing facility at its Changzhou campus.
read more
Rephine announced its merger with Barcelona-based GxP audit organization Forum Auditorias and its technology and manufacturing supply chain compliance consultancy TDV.
read more